ストックスクリーナーアプリを入手
61.07
3.09%
1.83
前日終値:
$59.24
開ける：
$60.48
24時間の取引高:
43.18M
Relative Volume:
1.14
時価総額：
$12.37B
収益：
$1.78B
当期純損益:
$164.40M
株価収益率:
88.51
EPS:
0.69
ネットキャッシュフロー:
$236.51M
1週間 パフォーマンス:
+6.10%
1か月 パフォーマンス:
-5.54%
6か月 パフォーマンス:
+113.91%
1年 パフォーマンス:
+146.35%
1日の値動き範囲:
$58.15
$62.54
1週間の範囲:
$54.67
$62.54
52週間の値動き範囲:
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
名前
Hims Hers Health Inc
電話
415-851-0195
住所
2269 CHESTNUT ST, SAN FRANCISCO
HIMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
61.07 | 12.37B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
158.02 | 381.79B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
62.10 | 154.84B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
88.19 | 74.51B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KMB
Kimberly Clark Corp
|
127.96 | 44.14B | 19.75B | 2.47B | 2.39B | 7.34 |
|
KVUE
Kenvue Inc
|
21.36 | 41.32B | 15.30B | 1.06B | 1.45B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
Hims & Hers Goes Global, Named To Top Stocks List: Build Your Growth Stock Watchlist With These Just Updated Screens - Investor's Business Daily
Where Will Hims & Hers Stock Be In 10 Years? - Barchart.com
Hims & Hers Health Inc Stock: Navigating High Volatility and a Rich Valuation - Daily Chhattisgarh News
Bet on Winning DuPont Analysis & Pick 3 Top Stocks - Yahoo Finance
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth) - Barchart.com
Hims & Hers Health Annual Stockholders Meeting Results - TipRanks
Hims & Hers (HIMS) Stock Pauses After Explosive 134% Rally This Year, Highlighting Immense Growth - Daily Chhattisgarh News
These 2 Growth Stocks Are No-Brainer Buys Right Now - Yahoo Finance
VF Corp, MGM Resorts, PENN Entertainment, Hims & Hers Health, and Camping World Shares Are Soaring, What You Need To Know - Yahoo Finance
2 Reasons To Double Down On Hims & Hers Ahead Of August (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Stock Skyrockets Over 8%, Extending a Phenomenal 147% Annual Gain - Daily Chhattisgarh News
Where are the Opportunities in (HIMS) - news.stocktradersdaily.com
Hims & Hers: An Excellent Subscription Business - Seeking Alpha
The controversial rise of Franken-pills: Telehealth companies push to mix meds in a single pill - Sherwood News
Hims & Hers (HIMS) Stock Dips Amid Profit-Taking, But Yearly Gains Exceed a Massive 134% - Daily Chhattisgarh News
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Hims & Hers Health and Sociedad Quimica y Minera de Chile have been highlighted as Zacks Bull and Bear of the Day - Zacks Investment Research
Where Will Hims & Hers Stock Be in 10 Years? - The Globe and Mail
Noteworthy Thursday Option Activity: PARR, VZ, HIMS - Nasdaq
Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth - Yahoo Finance
Hims & Hers (HIMS) Share Price Shows Explosive Growth, Surging Over 150% in a Year - Daily Chhattisgarh News
June 2025's Select Stocks That Could Be Trading Below Estimated Value - simplywall.st
Hims & Hers Health’s (HIMS) Equal Weight Rating Reaffirmed at Morgan Stanley - Defense World
3 Reasons We Love Hims & Hers Health (HIMS) - Yahoo Finance
HIMS Experiences Mixed Growth in App Downloads and Web Traffic | - GuruFocus
Hims & Hers (HIMS) Stock Soars, Capping a Year of Explosive Growth - Daily Chhattisgarh News
Hims & Hers Stock Falls After Eli Lilly Rules Out Telehealth Tie-Up: Citi Calls It Aggressive Stance, Retail Turns Bearish - MSN
Hims & Hers: The ZAVA Acquisition Catapults Growth In Europe's Weight-Loss Market - Seeking Alpha
Lilly Pacts Bar Telehealth Firms From Selling Copycat Zepbound - MSN
Needham Lifts PT on Hims & Hers Health (HIMS) Stock, Maintains Buy Rating - MSN
Hims & Hers Health (NYSE:HIMS) Shares Down 1.8% on Insider Selling - Defense World
Citi Keeps Hims & Hers (HIMS) Price Target, Maintains Sell Rating - MSN
HIMS Faces Uncertain Future with Potential Eli Lilly Partnership - GuruFocus
Is Hims & Hers Health a Smart Buy Right Now? - MSN
Lilly Pacts Prohibit Telehealth Sales of Copycat Zepbound - Bloomberg.com
Hims & Hers stock falls after Lilly rules out partnership - Investing.com Australia
Lilly (LLY) Pacts Bar Telehealth Firms From Selling Copycat Zepbound - Bloomberg.com
Hims & Hers says its weight-loss business can grow as US market changes - Reuters
Bought $40,000 of Hims & Hers (HIMS) Stock on a YOLO – Is it Time to Sell? - AOL.com
Hims & Hers Health's Strategy in the Evolving Weight-Loss Drug MarketNews and Statistics - IndexBox
Hims & Hers (NYSE: HIMS) Live: Complete Earnings Coverage - AOL.com
Bought $40,000 of Hims & Hers (HIMS) Stock on a YOLOIs it Time to Sell? - 24/7 Wall St.
Hims & Hers (HIMS) Stock Stays Flat After Volatile Session, Highlighting Massive Yearly Gains - Daily Chhattisgarh News
Analysis: Hims & Hers says its weight-loss business can grow as US market changes - Yahoo Finance
Why Hims & Hers Health (HIMS) Might be Well Poised for a Surge - Yahoo Finance
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey
Hims & Hers Health Unusual Options Activity - Nasdaq
Hims & Hers (HIMS) Stock Tumbles 10% in a Week, Pausing a Meteoric 160% Annual Rally - Daily Chhattisgarh News
Hims & Hers Health and AST SpaceMobile have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Hims & Hers Health, Inc. (NYSE:HIMS) Receives Consensus Rating of “Hold” from Analysts - Defense World
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
Hims Hers Health Inc (HIMS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Dudum Andrew | Chief Executive Officer |
Jun 16 '25 |
Option Exercise |
2.43 |
125,335 |
304,564 |
285,550 |
| Dudum Andrew | Chief Executive Officer |
Jun 16 '25 |
Sale |
56.76 |
128,127 |
7,271,950 |
160,215 |
| Dudum Andrew | Chief Executive Officer |
Jun 17 '25 |
Sale |
59.22 |
65,110 |
3,855,542 |
95,105 |
| Dudum Andrew | Chief Executive Officer |
Jun 16 '25 |
Sale |
56.51 |
47,534 |
2,686,300 |
237,660 |
| Boughton Soleil | Chief Legal Officer |
Jun 16 '25 |
Sale |
56.80 |
5,451 |
309,617 |
165,881 |
| Boughton Soleil | Chief Legal Officer |
Jun 17 '25 |
Sale |
59.75 |
2,572 |
153,677 |
163,309 |
| Becklund Irene | PAO |
Jun 17 '25 |
Sale |
59.75 |
8,485 |
506,979 |
712 |
0.96%
大文字化:
|
ボリューム (24 時間):